Comment from the Editor on the Special Issue “Head and Neck Critical Illness: Basic and Clinical Research Implications”
While oncogenic mutations of head and neck squamous cell carcinomas (HNSCC) in head and neck malignancies are uncommon, analysis using next-generation sequencing (NGS) technologies is growing. Further, single-cell analysis is being developed to overcome cancer cell heterogeneity and improve the poor...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/11/1905 |
id |
doaj-69be0466ce5c403facb7bc2ed2b5eead |
---|---|
record_format |
Article |
spelling |
doaj-69be0466ce5c403facb7bc2ed2b5eead2020-11-25T02:27:40ZengMDPI AGJournal of Clinical Medicine2077-03832019-11-01811190510.3390/jcm8111905jcm8111905Comment from the Editor on the Special Issue “Head and Neck Critical Illness: Basic and Clinical Research Implications”Hiroyuki Tomita0Department of Tumor Pathology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, JapanWhile oncogenic mutations of head and neck squamous cell carcinomas (HNSCC) in head and neck malignancies are uncommon, analysis using next-generation sequencing (NGS) technologies is growing. Further, single-cell analysis is being developed to overcome cancer cell heterogeneity and improve the poor survival of patients. However, it is important for researchers to know how to use this information to improve patients’ survival.https://www.mdpi.com/2077-0383/8/11/1905head and neck cancerngssquamous cell carcinoma |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hiroyuki Tomita |
spellingShingle |
Hiroyuki Tomita Comment from the Editor on the Special Issue “Head and Neck Critical Illness: Basic and Clinical Research Implications” Journal of Clinical Medicine head and neck cancer ngs squamous cell carcinoma |
author_facet |
Hiroyuki Tomita |
author_sort |
Hiroyuki Tomita |
title |
Comment from the Editor on the Special Issue “Head and Neck Critical Illness: Basic and Clinical Research Implications” |
title_short |
Comment from the Editor on the Special Issue “Head and Neck Critical Illness: Basic and Clinical Research Implications” |
title_full |
Comment from the Editor on the Special Issue “Head and Neck Critical Illness: Basic and Clinical Research Implications” |
title_fullStr |
Comment from the Editor on the Special Issue “Head and Neck Critical Illness: Basic and Clinical Research Implications” |
title_full_unstemmed |
Comment from the Editor on the Special Issue “Head and Neck Critical Illness: Basic and Clinical Research Implications” |
title_sort |
comment from the editor on the special issue “head and neck critical illness: basic and clinical research implications” |
publisher |
MDPI AG |
series |
Journal of Clinical Medicine |
issn |
2077-0383 |
publishDate |
2019-11-01 |
description |
While oncogenic mutations of head and neck squamous cell carcinomas (HNSCC) in head and neck malignancies are uncommon, analysis using next-generation sequencing (NGS) technologies is growing. Further, single-cell analysis is being developed to overcome cancer cell heterogeneity and improve the poor survival of patients. However, it is important for researchers to know how to use this information to improve patients’ survival. |
topic |
head and neck cancer ngs squamous cell carcinoma |
url |
https://www.mdpi.com/2077-0383/8/11/1905 |
work_keys_str_mv |
AT hiroyukitomita commentfromtheeditoronthespecialissueheadandneckcriticalillnessbasicandclinicalresearchimplications |
_version_ |
1724841559469326336 |